Evaluation of the Combination of Cytology and Hybrid Capture to Safely Predict the High-Grade Lesion Status of Patients Treated with Conization with Large Loop Excision of the Transformation Zone

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author RONCAGLIA, Maria Teresa FMUSP-HC
TACLA, Maricy FMUSP-HC
MOTTA, Eduardo Vieira da FMUSP-HC
CAIAFFA, Helio FMUSP-HC
AB'SABER, Alexandre FMUSP-HC
ALVES, Venancio Avancini Ferreira FMUSP-HC
LONGATTO FILHO, Adhemar FMUSP-HC
BARACAT, Edmund C. FMUSP-HC
dc.date.issued 2011
dc.identifier.citation ACTA CYTOLOGICA, v.55, n.5, p.421-425, 2011
dc.identifier.issn 0001-5547
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/23531
dc.description.abstract Objectives: This study aimed to verify whether human papillomavirus (HPV) testing after conization treatment has some potential usefulness for predicting patients' outcome. Study Design: One hundred and twenty women were treated for HSIL by conization with large loop excision of the transformation zone (LLETZ). Cytology, colposcopy-guided biopsy, and hybrid capture 2 (HC2) HPV DNA tests were performed before the surgical procedure and every 6 months for 2 years at follow-up. Results: More than 90% of the patients tested positive for high-risk HPV prior to the surgical intervention. Six months after the cervical conization, 74.75% of the patients tested negative for high-risk HPV DNA, and 19.41% were positive. Of the women who were HC2 negative, 72 showed normal cytological smears, 3 ASC-US, 2 LSIL, and 1 HSIL. Of those who were HC2 positive, 8 showed normal smears, 2 ASC-US, 2 ASC-H, 5 LSIL, and 1 case had HSIL, AGC, and squamous cells invasive carcinoma. Clinically, the HSIL case with a negative HPV test did not show any sign of high-grade lesions, and the clinical follow-up did not show residual lesions. Conclusions: Negative HPV tests correlated with freedom from high-grade disease after 2 years of postconization follow-up, which strongly suggests that negative HPV tests predict the absence of cervical disease.
dc.language.iso eng
dc.publisher KARGER
dc.relation.ispartof Acta Cytologica
dc.rights restrictedAccess
dc.subject Human papillomavirus; Hybrid capture; Conization; High-grade lesion
dc.subject.other cervical intraepithelial neoplasia; human-papillomavirus; women; cancer; hpv; persistence; lletz
dc.title Evaluation of the Combination of Cytology and Hybrid Capture to Safely Predict the High-Grade Lesion Status of Patients Treated with Conization with Large Loop Excision of the Transformation Zone
dc.type article
dc.rights.holder Copyright KARGER
dc.description.group LIM/14
dc.description.group LIM/03
dc.description.group LIM/58
dc.identifier.doi 10.1159/000330808
dc.identifier.pmid 21986168
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author RONCAGLIA, Maria Teresa:FM:
hcfmusp.author TACLA, Maricy:HC:ICHC
hcfmusp.author MOTTA, Eduardo Vieira da:HC:ICHC
hcfmusp.author CAIAFFA, Helio:HC:ICHC
hcfmusp.author AB'SABER, Alexandre:HC:ICHC
hcfmusp.author ALVES, Venancio Avancini Ferreira:FM:MPT
hcfmusp.author LONGATTO FILHO, Adhemar:HC:LIM/14
hcfmusp.author BARACAT, Edmund C.:FM:MOG
hcfmusp.origem.id WOS:000296242700005
hcfmusp.origem.id 2-s2.0-80155192497
hcfmusp.publisher.city BASEL
hcfmusp.publisher.country SWITZERLAND
hcfmusp.relation.reference · Parkin DM, 2005, CA-CANCER J CLIN, V55, P74
· Sarian LOZ, 2004, J CLIN VIROL, V31, P270, DOI 10.1016/j.jcv.2004.05.012
· Mitchell MF, 1998, OBSTET GYNECOL, V92, P737
· Verguts J, 2006, BJOG-INT J OBSTET GY, V113, P1303, DOI 10.1111/j.1471-0528.2006.01063.x
· Nuovo J, 2000, INT J GYNECOL OBSTET, V68, P25, DOI 10.1016/S0020-7292(99)00162-9
· Syrjanen K, 2009, INT J GYNECOL CANCER, V19, P934, DOI 10.1111/IGC.0b013e3181a834fe
· Zielinski GD, 2004, OBSTET GYNECOL SURV, V59, P543, DOI 10.1097/00006254-200407000-00024
· Kjaer SK, 2002, BRIT MED J, V325, P572, DOI 10.1136/bmj.325.7364.572
· BOSCH FX, 1995, J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796
· Holowaty P, 1999, J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252
· Chan BK, 2009, AM J OBSTET GYNECOL, V200, p422 e1
· CORDEIRO BPV, 2009, ESTIMATIVA 2010 INCI
· Flannelly G, 1997, BRIT J OBSTET GYNAEC, V104, P718, DOI 10.1111/j.1471-0528.1997.tb11983.x
· Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X
· PRENDIVILLE W, 1989, BRIT J OBSTET GYNAEC, V96, P1054, DOI 10.1111/j.1471-0528.1989.tb03380.x
dc.description.index MEDLINE
hcfmusp.citation.scopus 4
hcfmusp.scopus.lastupdate 2021-08-27


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics